Both in Pharmaceuticals
Citius Pharmaceuticals vs Bolt Biotherapeutics
Over the past year CTXR returned −65.1% and BOLT returned +15.0%; their daily moves had a correlation of 0.10.
CTXR −65.1% BOLT +15.0%Growth of $1, one year, split-adjusted
| Metric | CTXR | BOLT |
|---|---|---|
| Price | $0.5411 | $6.58 |
| Market cap | $14.9M | $15.5M |
| Today | +7.90% | +3.30% |
| 1 month | −2.4% | +82.8% |
| 6 months | −9.1% | +38.2% |
| Year to date | −30.4% | +20.3% |
| 1 year | −66.5% | +5.4% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | 67.1% | 100.0% |
| Net margin | −593.3% | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | 3.3× |
| Net cash | $10.6M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 112.9% | 111.3% |
| Short % of float | 21.9% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).